Appili Therapeutics, Inc. (APLIF)
0.0068
0.00 (0.00%)
USD |
OTCM |
Oct 26, 16:00
Appili Therapeutics Free Cash Flow : -1.022M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.022M |
| March 31, 2026 | -1.009M |
| December 31, 2025 | -0.0893M |
| September 30, 2025 | -0.2169M |
| June 30, 2025 | 0.6556M |
| March 31, 2025 | 0.5593M |
| December 31, 2024 | -0.5053M |
| September 30, 2024 | -0.002M |
| June 30, 2024 | -0.4793M |
| March 31, 2024 | -1.912M |
| December 31, 2023 | -2.396M |
| September 30, 2023 | -3.289M |
| June 30, 2023 | -5.483M |
| March 31, 2023 | -7.824M |
| Date | Value |
|---|---|
| December 31, 2022 | -10.06M |
| September 30, 2022 | -14.02M |
| June 30, 2022 | -13.70M |
| March 31, 2022 | -15.34M |
| December 31, 2021 | -15.72M |
| September 30, 2021 | -13.34M |
| June 30, 2021 | -13.31M |
| March 31, 2021 | -8.868M |
| December 31, 2020 | -6.273M |
| September 30, 2020 | -4.441M |
| June 30, 2020 | -3.180M |
| March 31, 2020 | -3.251M |
| December 31, 2019 | -2.877M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| InMed Pharmaceuticals, Inc. | -8.628M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -61.10M |
| Clearmind Medicine, Inc. | -6.997M |
| Lexaria Bioscience Corp. | -7.527M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.0267M |
| Cash from Financing (Quarterly) | 0.1232M |
| Free Cash Flow Per Share (Quarterly) | -0.0002 |
| Free Cash Flow to Equity (Quarterly) | -0.15M |
| Free Cash Flow to Firm (Quarterly) | 0.1561M |
| Free Cash Flow Yield | -116.9% |